MDSO News and Press, Medidata Solutions Inc. From 06/14/19

NEW YORK , June 14, 2019 /PRNewswire/ --  Juan Monteverde , founder and managing partner at Monteverde & Associates PC , a national securities firm headquartered at the Empire State Building in New York City , is investigating: Raytheon Company ( RTN ) ("Raytheon") ...

NEW YORK, June 12, 2019 (GLOBE NEWSWIRE) -- Halper Sadeh LLP, a global investor rights law firm, is investigating whether the sale of Medidata Solutions, Inc. (“Medidata” or the “Company”) (NASDAQ: MDSO) to Dassault Systèmes (“Dassault”) is fai...

It's official! Dassault Systemes ( OTCPK:DASTY ) has agreed to buy Medidata Solutions (NASDAQ: MDSO ), a U.S. software company dealing in the sphere of clinical trials, in a record deal for the company worth $5.8B on an enterprise value basis. More news on: Dassault Systèmes SE, Med...

Medidata Solutions’ market-leading clinical cloud solutions are used by 1,300 customers worldwide to develop their therapeutic innovations and clinical operations performance Scientific modeling, simulation and digital assets of worldwide trials knowledge and know-how combine...

The stock of Medidata ( MDSO ) continues to break new ground to the upside on the back of some strong fundamentals. How will this stock fare as we head into the home stretch of the second quarter of 2019? Fundamental Outlook The fundamentals for Medidata Solutions are strong, given the d...

Institute collaborates with leading influencers in life sciences to solve industry challenges and provide fresh perspectives Initial partnerships with Castleman Disease Collaborative Network and Friends of Cancer Research deliver insights that improve treatment options and reduce th...

Evaluation based upon market impact, plus vision and capability Medidata positioned as top company for impact created in market, which includes the criteria of market adoption, portfolio mix and value delivered Company also designated “Star Performer,” for achiev...

Medidata (NASDAQ: MDSO) today announced that Rouven Bergmann, chief financial officer, will present at the Jefferies 2019 Healthcare Conference on Thursday, June 6, 2019, at 9 a.m. ET in New York. A live audio webcast and replay of each presentation will be available at https://invest...

How data and technology enable more patients to receive the most promising new experimental therapies during a clinical trial - a collaboration with Friends of Cancer Research Friends of Cancer Research and Medidata present scientific innovation that reduces the number of patients ...

I run a stock-screen that I have named 'The Nosebleed' that filters for the most expensive or richly-priced stocks in the market. The purpose here is to find stocks that are metaphorically so "high up in the stands that the air is thin, and investors could begin to experience nasal hemorrhag...